http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AR-046665-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3cd12257804e2d7f96cff826faa97e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70
filingDate 2004-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fc863fcc9b298168344fa7b2932b7be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1f21d1a7f3d472bb692e1a541d2ba7c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3406eac39c46b539310e8ed034af885
publicationDate 2005-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber AR-046665-A1
titleOfInvention ORAL FORMULATIONS OF DEOXIPEGANINE AND ITS USES
abstract Medications in the form of a film, for oral administration, which contain the active substance deoxipeganin and / or a derivative of deoxipeganin and which can be used for administration through mucous membranes in particular, orally, of these active substances. Claim 16: Use of at least one centrally active cholinergic active ingredient, selected from the active ingredients named in claims 1 and 2, for the preparation of an oral medicament in the form of a film for the administration of the principle (s) for the treatment of diseases or symptoms of diseases, which are caused by a deficiency of acetylcholine or in which such deficiency occurs, as well as for the treatment of diseases in which there is a deficiency of endogenous amines and / or which may be favorably influenced by an inhibition of monoamine oxidase.
priorityDate 2003-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP56560
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19643
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ6NSN2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21396
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO18851
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21397
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP49253
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP21398
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27338
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP46882
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485969
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID187
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ64133
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54IT3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ556K4
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8BW75

Total number of triples: 44.